Guidant Profiting From Medtronic Rapid Exchange Exit
This article was originally published in The Gray Sheet
Executive Summary
Guidant is already reaping the benefit of Medtronic's pullout from the U.S. rapid-exchange delivery market and intends to build on its vascular intervention unit's strong financial performance in the third quarter going forward.